Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03500952 · ClinicalTrials.gov registry record · NA
Family Planning Ahead
A NA study, sponsored by Dartmouth-Hitchcock Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 41
- Enrollment target
NCT03500952 is a NA study that was terminated before completion, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 41 participants.
The verdict
NCT03500952, a NA study, was terminated before completion, sponsored by Dartmouth-Hitchcock Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
Study Summary
Family Planning Ahead is a study that aims to improve decision-making about postpartum contraception. Family Planning Ahead will test two different strategies: a patient decision aid and a patient information leaflet.
Interventions
- OTHER Birth Control After Pregnancy
- OTHER Postpartum Birth Control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2018-03-22 |
| Est. Completion | 2018-08-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03500952
The ClinicalTrials.gov registry entry for NCT03500952 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Birth Control After Pregnancy is the first listed.
NCT03500952 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03500952 about?
NCT03500952 is a clinical study titled "Family Planning Ahead". Family Planning Ahead is a study that aims to improve decision-making about postpartum contraception. Family Planning Ahead will test two different strategies: a patient decision aid and a patient information leaflet.
What is the current status of trial NCT03500952?
This trial is currently terminated. It is a NA study. The enrollment target is 41 participants. The study started on 2018-03-22. Estimated completion is 2018-08-23.
What interventions are being tested in trial NCT03500952?
The interventions under investigation include: Birth Control After Pregnancy (OTHER), Postpartum Birth Control (OTHER).
Who is sponsoring clinical trial NCT03500952?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.